Biblio

Export 366 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is C  [Clear All Filters]
2018
R. H Brashear, Ketter, N., Bogert, J., Di, J., Salloway, S. P., and Sperling, R., “Clinical Evaluation of Amyloid-Related Imaging Abnormalities in Bapineuzumab Phase III Studies.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1409-1424, 2018.
L. Tariciotti, Casadei, M., Honig, L. S., Teich, A. F., Ii, G. M. McKhann, Tosto, G., and Mayeux, R., “Clinical Experience with Cerebrospinal Fluid Aβ42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1417-1425, 2018.
E. Morenas-Rodriguez, Sala, I., Subirana, A., Pascual-Goñi, E., Sánchez-Saudinós, M. Belén, Alcolea, D., Illán-Gala, I., Carmona-Iragui, M., Ribosa-Nogué, R., Camacho, V., Blesa, R., Fortea, J., and Lleo, A., “Clinical Subtypes of Dementia with Lewy Bodies Based on the Initial Clinical Presentation.”, J Alzheimers Dis, vol. 64, no. 2, pp. 505-513, 2018.
J. Cummings, Ritter, A., and Zhong, K., “Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future.”, J Alzheimers Dis, vol. 64, no. s1, pp. S3-S22, 2018.
M. Grassi, Perna, G., Caldirola, D., Schruers, K., Duara, R., and Loewenstein, D. A., “A Clinically-Translatable Machine Learning Algorithm for the Prediction of Alzheimer's Disease Conversion in Individuals with Mild and Premild Cognitive Impairment.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1555-1573, 2018.
J. A. Soria, Huisa, B. N., Edland, S. D., Litvan, I., Peavy, G. M., Salmon, D. P., Hansen, L. A., Galasko, D. R., Brewer, J. B., González, H. M., and Rissman, R. A., “Clinical-Neuropathological Correlations of Alzheimer's Disease and Related Dementias in Latino Volunteers.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1539-1548, 2018.
I. Álvarez, Aguilar, M., González, J. Manuel, Ysamat, M., Lorenzo-Bosquet, C., Alonso, A., Tartari, J. Pablo, Romero, S., Diez-Fairen, M., Carcel, M., Pujalte, F., and Pastor, P., “Clinic-Based Validation of Cerebrospinal Fluid Biomarkers with Florbetapir PET for Diagnosis of Dementia.”, J Alzheimers Dis, vol. 61, no. 1, pp. 135-143, 2018.
M. L. Alosco, Sugarman, M. A., Besser, L. M., Tripodis, Y., Martin, B., Palmisano, J. N., Kowall, N. W., Au, R., Mez, J., DeCarli, C., Stein, T. D., McKee, A. C., Killiany, R. J., and Stern, R. A., “A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1347-1360, 2018.
R. Thangavel, Bhagavan, S. M., Ramaswamy, S. Beladakere, Surpur, S., Govindarajan, R., Kempuraj, D., Zaheer, S., Raikwar, S., Ahmed, M. E., Selvakumar, G. Pushpavath, Iyer, S. S., and Zaheer, A., “Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain.”, J Alzheimers Dis, vol. 61, no. 2, pp. 553-560, 2018.
C. M. Huber, Yee, C., May, T., Dhanala, A., and Mitchell, C. S., “Cognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy.”, J Alzheimers Dis, vol. 61, no. 1, pp. 265-281, 2018.
N. Malandrino, Capristo, E., Taveira, T. H., Mingrone, G., and Wu, W. - C., “Cognitive Function in Individuals with Normal Weight Obesity: Results from the Third National Health and Nutrition Examination Survey (NHANES III).”, J Alzheimers Dis, vol. 65, no. 1, pp. 125-135, 2018.
S. Angermann, Schier, J., Baumann, M., Steubl, D., Hauser, C., Lorenz, G., Günthner, R., Braunisch, M. C., Kemmner, S., Satanovskij, R., Haller, B., Heemann, U., Lehnert, T., Bieber, R., Pachmann, M., Braun, J., Scherf, J., Schätzle, G., Fischereder, M., Grimmer, T., and Schmaderer, C., “Cognitive Impairment is Associated with Mortality in Hemodialysis Patients.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1529-1537, 2018.
F. Burgio, Delazer, M., Meneghello, F., Pertl, M. - T., Semenza, C., and Zamarian, L., “Cognitive Training Improves Ratio Processing and Decision Making in Patients with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1213-1226, 2018.
C. E. Gleason, Norton, D., Anderson, E. D., Wahoske, M., Washington, D. T., Umucu, E., Koscik, R. L., N Dowling, M., Johnson, S. C., Carlsson, C. M., and Asthana, S., “Cognitive Variability Predicts Incident Alzheimer's Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker.”, J Alzheimers Dis, vol. 61, no. 1, pp. 79-89, 2018.
S. Yumoto, Kakimi, S., and Ishikawa, A., “Colocalization of Aluminum and Iron in Nuclei of Nerve Cells in Brains of Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1267-1281, 2018.
T. Kishi, Matsuda, Y., and Iwata, N., “Combination Therapy of Serotonin Reuptake Inhibitors and Memantine for Obsessive- Compulsive Disorder: A Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials.”, J Alzheimers Dis, vol. 64, no. 1, pp. 43-48, 2018.
A. Dodich, Cerami, C., Cappa, S. F., Marcone, A., Golzi, V., Zamboni, M., Giusti, M. Cristina, and Iannaccone, S., “Combined Socio-Behavioral Evaluation Improves the Differential Diagnosis Between the Behavioral Variant of Frontotemporal Dementia and Alzheimer's Disease: In Search of Neuropsychological Markers.”, J Alzheimers Dis, vol. 61, no. 2, pp. 761-772, 2018.
N. M. Payton, Kalpouzos, G., Rizzuto, D., Fratiglioni, L., Kivipelto, M., Bäckman, L., and Laukka, E. J., “Combining Cognitive, Genetic, and Structural Neuroimaging Markers to Identify Individuals with Increased Dementia Risk.”, J Alzheimers Dis, vol. 64, no. 2, pp. 533-542, 2018.
P. Gavin Kehoe, “The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?”, J Alzheimers Dis, vol. 62, no. 3, pp. 1443-1466, 2018.
M. - S. Tan, Wang, P., Ma, F. - C., Li, J. - Q., Tan, C. - C., Yu, J. - T., and Tan, L., “Common Variant in PLD3 Influencing Cerebrospinal Fluid Total Tau Levels and Hippocampal Volumes in Mild Cognitive Impairment Patients from the ADNI Cohort.”, J Alzheimers Dis, vol. 65, no. 3, pp. 871-876, 2018.
J. - L. Berg, Durant, J., Léger, G. C., Cummings, J. L., Nasreddine, Z., and Miller, J. B., “Comparing the Electronic and Standard Versions of the Montreal Cognitive Assessment in an Outpatient Memory Disorders Clinic: A Validation Study.”, J Alzheimers Dis, vol. 62, no. 1, pp. 93-97, 2018.
J. A. Matías-Guiu, Cabrera-Martín, M. Nieves, Curiel, R. E., Valles-Salgado, M., Rognoni, T., Moreno-Ramos, T., Carreras, J. Luis, Loewenstein, D. A., and Matías-Guiu, J., “Comparison between FCSRT and LASSI-L to Detect Early Stage Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 103-111, 2018.
M. Dyrba, Grothe, M. J., Mohammadi, A., Binder, H., Kirste, T., and Teipel, S. J., “Comparison of Different Hypotheses Regarding the Spread of Alzheimer's Disease Using Markov Random Fields and Multimodal Imaging.”, J Alzheimers Dis, vol. 65, no. 3, pp. 731-746, 2018.
A. Medoro, Bartollino, S., Mignogna, D., Passarella, D., Porcile, C., Pagano, A., Florio, T., Nizzari, M., Guerra, G., Di Marco, R., Intrieri, M., Raimo, G., and Russo, C., “Complexity and Selectivity of γ-Secretase Cleavage on Multiple Substrates: Consequences in Alzheimer's Disease and Cancer.”, J Alzheimers Dis, vol. 61, no. 1, pp. 1-15, 2018.
T. Dunkelmann, Schemmert, S., Honold, D., Teichmann, K., Butzküven, E., Demuth, H. - U., Shah, N. Joni, Langen, K. - J., Kutzsche, J., Willbold, D., and Willuweit, A., “Comprehensive Characterization of the Pyroglutamate Amyloid-β Induced Motor Neurodegenerative Phenotype of TBA2.1 Mice.”, J Alzheimers Dis, vol. 63, no. 1, pp. 115-130, 2018.

Pages